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ScienceDirectA revolution in sequencing technologies in recent years has led
to dramatically increased throughput and reduced cost of
bacterial genome sequencing. An increasing number of
applications of the new technologies are providing broad
insights into bacterial evolution, epidemiology, and
pathogenesis. For example, the capacity to sequence large
numbers of bacterial isolates is enabling high resolution
phylogenetic analyses of bacterial populations leading to
greatly enhanced understanding of the emergence, adaptation,
and transmission of pathogenic clones. In addition, RNA-seq
offers improved quantification and resolution for transcriptomic
analysis, and the combination of high-throughput sequencing
with transposon mutagenesis is a powerful approach for the
identification of bacterial determinants required for survival in
vivo. In this concise review we provide selected examples of
how high throughput sequencing is being applied to
understand the biology of bacterial pathogens, and discuss
future technological advances likely to have a profound impact
on the field.
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Introduction
The development of new technologies enabling rapid,
inexpensive, and high-throughput DNA sequencing
(HTS) that offer clear advantages over traditional Sanger
sequencing has revolutionized the field of bacterial geno-
mics [1,2]. Furthermore, the recent development of
high-throughput ‘benchtop’ sequencers is empowering
laboratories to sequence their bacteria of interest inde-
pendently of specialist sequencing centres [2,3]. An array
of different technologies have been developed with the
common feature that they parallelize the sequencingCurrent Opinion in Microbiology 2014, 19:106–113 process, leading to the production of thousands or
millions of sequence reads concurrently (for a review of
the HTS technologies see [1,2]). HTS is being applied in
a myriad of ways to address fundamental questions con-
cerning the biology of infectious diseases. The high
resolution offered by HTS allows the inference of trans-
mission pathways during global pandemics and localized
outbreaks, identification of molecular mechanisms under-
pinning the emergence of pathogenic clones, and the
evolutionary analysis of bacterial populations during in-
fection of individual patients. HTS also provides the
potential for transcriptomic analyses with advantages over
traditional hybridization approaches, including genome-
wide coverage, accurate quantification, and single nucleo-
tide resolution (for recent comprehensive reviews, see
[4,5]). In addition, the combination of HTS with trans-
poson mutagenesis leading to the development of
approaches such as Tn-seq [6], transposon-directed inser-
tion site sequencing (TraDIS) [7], insertion sequencing
(INseq) [8], and high-throughput insertion tracking by
deep sequencing (HITS) [9] has facilitated the screening
of libraries of hundreds of thousands of bacterial mutants
to identify determinants required for survival during
growth in vivo or in other specific growth conditions
(for recent comprehensive reviews see [10,11]).
In the current concise review, we will summarize selected
recent studies that have applied HTS to answer important
questions regarding the success of major bacterial patho-
gens. We provide an overview of some of the insights
which can be derived from the application of these
techniques.
Study of bacterial evolution during infection
The progression and outcome of infectious disease is
determined by the dynamics of host–pathogen inter-
actions, and recent studies employing HTS have offered
novel insights into the evolution of bacterial pathogens
during the course of colonization and infection
[12,13,14,15]. For example, an emerging theme in
infectious disease research is the extent of genetic and
phenotypic diversification that may occur among the
infecting bacterial population within an individual host.
In particular, Pseudomonas aeruginosa, Staphylococcus aur-
eus, Mycobacterium abscessus, Mycobacterium tuberculosis, and
Burkholderia dolosa have been demonstrated to undergo
considerable diversification during infection, resulting in
‘clouds of diversity’ that originated from a single or closely
related group of infecting bacteria [12,14,15,16,17,18].
During infection, random advantageous mutations maywww.sciencedirect.com
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Schematic diagram summarizing the applications of high throughput sequencing for studies of the epidemiology, evolution and pathogenesis of
bacterial infections.become fixed within sub-populations, due to selective
pressures such as co-infection with other microorganisms,
the host immune response, and antimicrobial chemother-
apy [12,14,15,17,18,19]. Of note, cystic fibrosis (CF)
patients are at particular risk of pulmonary infections, and
a number of studies have utilized HTS to examine the
genetic diversification of bacterial populations during
long-term infection of CF patients [12,15,18,20]. For
example, convergent evolution represented by indepen-
dent mutations affecting O-antigen switching has been
identified in chronic B. dolosa infections [15]. Further-
more, mutations influencing the smooth to rough mor-
photype transition of M. abscessus spp. during infection of
the CF lung have been identified [20,21], and distinct
polymorphisms of loci influencing the alternative sigma
factor (SigB) of S. aureus were identified in multiple sub-
lineages of S. aureus within a single CF patient [18]. The
study also revealed mutations underlying antibiotic resist-
ance which occurred during infection as demonstrated in
other studies of S. aureus chronic infection [22,23]. Loss of
virulence factor production has also been described
during therapeutic Escherichia coli colonization of human
patients with recurrent urinary tract infections [24].
Numerous mutations associated with reduced virulence
and adaptation to oxidative stresses, and the recurrence of
mutations within individual patients strongly suggested
that host-specific selective pressures influence microevo-
lution during infection [24]. In addition, a long term S.
aureus carriage study identified an overall pattern of
purifying selection within asymptomatically colonized
hosts [13]. An enrichment of premature stop codonswww.sciencedirect.com was observed in invasive bloodstream isolates when
compared to carriage isolates from an individual who
developed a fatal bacteraemia, implying that specific
genetic changes in carriage isolates may be functionally
important in pathogenesis [14].
Differences in the composition of resident bacterial popu-
lations between healthy and disease states are increas-
ingly being described, and deep sequencing meta-
genomic methods can capture greater diversity from
the microbiota in comparison to traditional methods
relying on PCR amplification and Sanger sequencing
[25]. For example, decreased microbial diversity in CF
patients in comparison to healthy controls is associated
with more severe inflammation [26] and distinct shifts in
metabolic pathways have been identified [27]. Addition-
ally, the effects of antimicrobial therapies on the gut
microbiota have been investigated revealing increased
phage mobilization [28,29], and profound shifts in com-
position that persist after the cessation of therapy [30]
(Figure 1).
Identification of bacterial determinants
required for pathogenesis
The application of HTS for measuring the bacterial
transcriptome (RNA-seq) in different environmental con-
ditions has considerable advantages over traditional
hybridization-based techniques. The method requires
isolation of RNA followed by reverse transcription to
cDNA to allow library construction before HTS. Specifi-
cally, the inclusion of strain-specific genetic material,Current Opinion in Microbiology 2014, 19:106–113
108 Novel technologies in microbiologysingle base-pair resolution, and more accurate quantifi-
cation of relative levels of gene expression are improve-
ments on previous approaches using microarrays.
Although RNA-seq technology has been relatively slow
to be employed for bacterial transcriptomic studies due in
part to technical challenges of contaminating rRNA, an
increasing number of studies are now being published.
For example, comparative gene expression analysis of the
opportunistic human pathogen Aggregatibacter actinomyce-
temcomitans in vivo and in a biofilm model in vitro revealed
differential expression of 14% of the transcriptome, pro-
viding new information relevant to the metabolic path-
ways important for infection [31]. Other selected studies
have shown differential expression of master regulatory
genes in Streptococcus pneumoniae [6], genes essential for
the survival of Haemophilus influenzae outside of the host
[32], and survival of Salmonella Typhi in bile [7]. In
addition, RNA-seq identified the extent of the S. Typhi
ompR regulon [33] and revealed that the E. coli plasmid
pO157_sal regulates the expression of chromosomal
genes associated with the stress response, antibiotic
resistance, and virulence [34].
A particularly powerful application is the combination of
HTS with transposon mutagenesis. Briefly, libraries made
up of bacteria each with single transposon insertions into
non-essential genes are used as an innoculum for exper-
imental infections or for culture in defined conditions.
Subsequently, input and output populations are sub-
jected to HTS allowing the relative quantification of
mutants in each population. Accordingly, the comp-
lement of genes required for survival can be identified.
For example, the application of transposon-directed
insertion-site (TraDIS) sequencing to Salmonella enterica
serovars S. Typhi and S. Typhimurium revealed a con-
served core of 281 genes required for growth in both
serovars [35]. Attenuation of O-antigen genes and ferric
[Fe(III)] genes was observed in S. Typhimurium and S.
Typhi respectively [35], which may partly reflect the
distinct host tropisms of each serovar. A Tn-seq study
of adaptation of S. pneumoniae to the nasopharynx and the
lung indicated an array of genes associated with response
to hydrogen peroxide which were important during lung
infection, while genes associated with response to
temperature and sucrose were involved in survival in
the nasopharynx [36]. In contrast, a study of the inter-
actions of Moraxella catarrhalis with the host respiratory
epithelia reported no difference in expression of adhesion
factors between adhesive and planktonic states [37].
Finally, in a novel application of Tn-seq, the dynamics of
H. influenzae and influenza A virus co-infection were
examined in a mouse model of respiratory infection. Of
note, H. influenzae genes associated with oxidative stress
were required during co-infection with influenza A com-
pared to H. influenzae infection alone [38]. The use of
HTS-transposon approaches is revealing much about theCurrent Opinion in Microbiology 2014, 19:106–113 mechanisms of bacterial survival in vivo and in doing so
may indicate novel therapeutic targets for controlling
infection.
Identifying the source and transmission
routes of disease outbreaks
Traditional bacterial typing methods are often of limited
use for epidemiological investigations of infectious dis-
ease outbreaks due to their low level of discriminatory
power [39]. The comparison of whole genome sequences
can provide the ultimate level of nucleotide resolution
between bacterial isolates and accordingly has the
potential to identify transmission events within and
between hospitals and in the community [3,17,40,41,
42,43,44,45–47]. Importantly, the application of rapid
sequencing of suspected outbreak strains can inform
both clinical practice and infection control procedures
[17]. The level of genetic variation observed among
strains epidemiologically linked to an outbreak can help
determine whether a point source or multiple strains are
responsible [3,40,44,48]. For example, based on
multiple locus tandem repeats typing analysis, a clonal
population of M. tuberculosis was implicated as the cause
of a sustained outbreak of tuberculosis in Canada. How-
ever, in a seminal study by Gardy et al., integration of
genome sequence information and social network
analysis led to the discovery that the outbreak was
caused by two circulating lineages sustained by crack
cocaine users [44]. In addition, HTS has been applied
retrospectively to analyse S. aureus epidemics in hospi-
tals revealing the dynamics of outbreaks confined to
single hospital wards [3,40], and transmission between
the hospital and community settings [17]. The direc-
tionality of transmission, although often ambiguous, may
sometimes be inferred by combining epidemiological
data and analysis of bacterial population genome
sequences [12,15]. For example, in a study of Burkhol-
deria dolosa associated with chronic infections in a CF
patient cohort, transmission events could be inferred
from the phylogeny based on patterns of shared poly-
morphisms [15]. Also, a study of patients with M. absces-
sus subspecies massiliense pulmonary infections showed
greater genetic diversity among isolates from a single
patient than from different patients, suggestive of inter-
patient transmission events [12]. Recently, the devel-
opment of novel bioinformatic algorithms has facilitated
the identification of transmission events while account-
ing for the heterogeneity present in infecting bacterial
populations [49].
Understanding the molecular basis for the
emergence of pathogenic clones
The capacity to sequence large numbers of closely
related isolates allows high-resolution phylogenies to
be reconstructed, which may provide insights into the
processes underlying the emergence and spread of
pathogenic clones. Bacterial populations accumulatewww.sciencedirect.com
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rates specific for the organism and its ecology. Estimates
of the mutation rate for a given bacterial population
allow the construction of time-calibrated phylogenetic
trees [50]. In particular, the application of Bayesian
phylogenetic methods to sequences of closely related
bacteria, can allow a time-scaled reconstruction of their
evolutionary history and geographic dissemination, and
may also reveal genetic events that correlate with the
emergence of successful clones. The evolutionary
history of an increasing array of bacterial pathogens
has been examined using this approach including
S. aureus, Shigella sonnei, S. Typhimurium and Vibrio
cholerae [42,43,51–56]. In a concise review of this nature
we can provide just a few recent examples. Methicillin-
resistant S. aureus (MRSA) is an important cause of
nosocomial infection in the United Kingdom, and recent
studies have described genetic events preceding the
emergence of the major hospital-adapted lineages
EMRSA-15 and EMRSA-16, including polymorphisms
associated with increased antimicrobial resistance and
reduced virulence [42,43]. The reduction in virulence
likely represents a fitness compensation in response to
the increased energy costs associated with antibiotic
resistance. In addition, a recent HTS study of invasive
S. Typhimurium circulating in sub-Saharan Africa
revealed the existence of two distinct epidemics that
correlated strongly with peaks in HIV incidence in the
region, suggesting that the increased number of immu-
nocompromised hosts in sub-Saharan Africa has been a
major contributor to the success of invasive S. Typhi-
murium [53]. Similarly, a study of S. Typhimurium
DT104 from livestock and human hosts employed Baye-
sian phylogenetic methods with extended analysis of
host-tropism using Markov jump methods to demon-
strate that circulating DT104 strains represent indepen-
dent epidemics. The data indicated that there had been
limited cross-species transmission, contradicting a
long-standing assumption regarding the zoonotic spread
of S. Typhimurium [54].
In another HTS-based evolutionary study, it was demon-
strated that the 7th cholera pandemic comprised of three
independent waves, with the latter two being driven
through acquisition of the SXT antibiotic resistance
element by V. cholerae. This resulted in resistance to
the commonly used anti-cholera therapies [52]. In the
aftermath of the 2010 earthquake in Haiti, the country
suffered from a prolonged outbreak of cholera. Phyloge-
netic reconstruction based on whole genome sequences
of V. cholerae from affected patients identified several
intercontinental transmission events originating from a
source population in the Bay of Bengal [52]. Further
analysis revealed that Haitian epidemic strains are related
to strains circulating in Nepal, implicating movements of
Nepali peacekeepers in the emergence of the epidemic
[55] following a single introduction to Haiti [56].www.sciencedirect.com The impact of human clinical interventions on the emer-
gence of successful bacterial clones has been demon-
strated for the S. pneumoniae PMEN1 lineage [57,58].
Following introduction of a conjugate polysaccharide
vaccine, capsule switching was observed [57] leading
to the emergence of the vaccine escape serotype 19A.
It was revealed that the geographic distribution of ser-
otype 19A has rapidly expanded to replace vaccine-
susceptible serotypes [58]. Further work based on
HTS of 616 S. pneumoniae isolates identified variation
in recombination rates between branches of the species’
phylogeny and also revealed an association between
specific genetic determinants of S. pneumoniae and the
age of the host. These data are consistent with adaptation
of S. pneumoniae in response to the maturing host immune
response [59].
HTS also played a central role in the near real-time
characterization of a high mortality outbreak of haemo-
lytic-uraemic syndrome (HUS) in central Europe during
2011 [60–62], rapidly revealing that the increased viru-
lence of the O104:H4 outbreak was likely due to acqui-
sition of a Shiga-toxin encoding prophage [62], and that
the strain was refractory to antibiotic therapy due to
carriage of an extended spectrum b-lactamase [60].
The molecular basis of bacterial host switches
The high resolution phylogenetic analysis possible using
HTS has enhanced our understanding of the capacity of
bacterial pathogens to switch host species and adapt to
survive and spread among novel host populations [51,63–
66]. In particular, several studies have identified livestock
as reservoirs for emerging bacterial strains capable of
causing disease in humans [51,63,65]. For example, Price
et al. examined the multi-host association of the ST398
clone of S. aureus by HTS providing evidence for the
emergence of antibiotic resistant strains resulting from
the use of antibiotics in the livestock industry [63].
Similarly, Spoor et al. demonstrated that cows are a
potential reservoir of new strains of S. aureus with the
capacity for pandemic spread in humans [51].
In addition to understanding the dynamics of cross-
species transmission, HTS allows high-resolution analysis
of genetic correlates of host specificity. For example, in
one of the few genome-wide association studies (GWAS)
of bacteria to be carried out, Shepphard et al. identified a
genomic region encoding vitamin B5 biosynthesis com-
ponents which is associated with adaptation of Campylo-
bacter jejuni to the bovine host [67]. Also, a S.
Typhimurium ST4/74 transposon mutant pool was used
to infect avian, bovine, and porcine hosts revealing hos-
t-specific gene repertoires, including genes associated
with anaerobic growth in the avian host [68]. Finally,
HTS of isolates of the host-restricted DT2 lineage of
S. Typhimurium and closely related strains suggested
that adaptation of the DT2 lineage to the rock pigeon wasCurrent Opinion in Microbiology 2014, 19:106–113
110 Novel technologies in microbiologynot mediated by acquisition of novel genetic material, but
rather by polymorphisms in the pre-existing genetic
repertoire [69].
Future applications of HTS for understanding
the biology of bacterial pathogens
The pace of development of sequencing technologies
shows no sign of slowing, and platforms capable of single-
molecule sequencing and ever increasing read lengths
offer the possibility of highly accurate assemblies of
individual pathogens within a microbial community
[70]. While bacterial culture has previously been an
essential step for the isolation of enough genomic
DNA for whole genome sequencing, novel culture-free
methodologies offer the ability to sequence un-culturable
organisms. Such applications have relevance for investi-
gating the cause of infectious diseases of unknown aetiol-
ogy. Furthermore, the rapid diagnosis and in silico
determination of sensitivity profiles of pathogens without
the necessity for culture have obvious benefits for the
treatment of clinical infections [71,72]. Furthermore,
transcriptomic analysis of complex populations of bacteria
within the microbiota will be theoretically feasible. To
date, transcriptomic studies have focused on either the
pathogen or the host. However, a comprehensive un-
derstanding of host–pathogen interactions would require
simultaneous analysis of gene expression of both parties
during infection. Dual RNA-seq offers the potential for
transcriptomic analysis of both host and pathogen during
the course of colonization and infection but there are
technical difficulties to overcome before routine imple-
mentation of this technology is feasible, including
removal of both bacterial and host rRNA, and large scale
differences in relative amounts of RNA for host and
pathogen [73]. Finally, the availability of genome
sequences for large numbers of well-defined clinical
isolates lends itself to the application of GWAS to bac-
teria, a method originally developed for human genetic
association analysis which has the potential for unbiased
identification of genetic determinants associated with a
given phenotype [74]. For example molecular correlates
of virulence or host-specificity may be determined
through simultaneous analysis of genome data and the
results from virulence assays [67,75,76].
Overall the development of HTS technologies has revo-
lutionized how we approach fundamental research into
infectious diseases. Without doubt the new approaches
will result in a very enhanced understanding of the
biology of bacterial pathogens which will ultimately lead
to improved infection control.
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